MY ACCOUNT | NEWSLETTER |

Pet food sales increased by 15% from 2020-21


The market for sales of pet food for cats and dogs was valued at $41 billion in 2021, based on a report by Packaged Facts, a division of MarketResearch.com. The increase in the market was 15% from 2020 to 2021. In addition, the Compound Annual Growth Rate, or CAGR, of the forecast period of 2017 to 2021 was 11%, according to the report.  

While the recent price spikes have been behind some of the growth, the market is also thought to be somewhat protected from cost pressures on consumers. In other words, while high prices have led some consumers to not buy products in some sectors, the pet food market remains resilient, according to a news release from Packaged Facts. The trend of and appeal to consumers for fresh pet food that requires refrigeration or freezing — like human food — is just one example of what the company describes as a market revolution.  

Effective brands in the fresh pet food space including Freshpet have predicted revenue greater than $1 billion as the sector approaches 2025. In addition, other large pet food companies have begun to offer lines of refrigerated dog food and have begun to acquire smaller fresh pet food brands.   

Habits of pet owners have changed in recent years with only half of cat and dog owners still purchasing traditional or adult formulation pet food.  

According to Packaged Reports, pet owners respond to the notion of food that is vetted by science: 36% of cat owners and 38% of dog owners have expressed support for pet food that is created based on research. As a nod to these numbers, Hill’s Prescription Diet pet food saw an increase of 14% in full year net sales, to $3.3 billion. 

Packaged Facts publishes market intelligence on a wide range of consumer market topics, including consumer demographics and shopper insights, consumer financial products and services, consumer goods and retailing, and pet products and services. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Legacy fuels UWVC leadership in comprehensive cancer care

Like0
Dislike0

DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing

Like0
Dislike0

From companion animals to patients interspecies lessons in neuroendocrine oncology.

Like0
Dislike0

Clinical signs, management, and survival of 278 dogs diagnosed with insulinoma under primary veterinary care in the United Kingdom.

Like0
Dislike0

Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top